APA (7th ed.) Citation

Sang-Woo Park, Jiwoong Lee, & Michael S. Kook. (2022). Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease. MDPI AG.

Chicago Style (17th ed.) Citation

Sang-Woo Park, Jiwoong Lee, and Michael S. Kook. Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease. MDPI AG, 2022.

MLA (9th ed.) Citation

Sang-Woo Park, et al. Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease. MDPI AG, 2022.